Amanda Norton
Adult Health · Bellevue, WANPI 1508309824
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,217 of the $7,828 with a category attached, or 79.4%. It is spread thinly across 24 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,438 and has fallen 74.1% since, to $630 in 2025. Among adult health clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 243 payments — averaging $32.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Dermavant Sciences, Inc.$1K
- Johnson & Johnson$682
- LEO Pharma Inc.$633
- UCB, Inc.$611
- Sanofi$533
- plus $3K from 18 others
What the payments were for
- Consulting fees$1,11014%
- Travel & lodging$190%
- Food & beverage$6,21779%
- Education$4826%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 74 | $1,487 |
| Dermavant Sciences, Inc. | 10 | $1,191 |
| Johnson & Johnson | 33 | $682 |
| LEO Pharma Inc. | 9 | $633 |
| UCB, Inc. | 16 | $611 |
| Sanofi | 12 | $533 |
| E.r. Squibb & Sons, L.L.C. | 19 | $448 |
| Incyte Corporation | 14 | $330 |
| Lilly USA, LLC | 14 | $328 |
| Regeneron Healthcare Solutions, Inc. | 10 | $300 |
| Galderma Laboratories, L.p. | 4 | $230 |
| Novartis | 6 | $156 |
| Janssen Scientific Affairs, LLC | 1 | $147 |
| VYNE Pharmaceuticals Inc. | 4 | $145 |
| Arcutis Biotherapeutics, Inc. | 2 | $130 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $127 |
| Sanofi-aventis U.S. LLC | 3 | $102 |
| Stemline Therapeutics Inc. | 1 | $69 |
| Sun Pharmaceutical Industries Inc. | 4 | $67 |
| Boehringer Ingelheim | 2 | $36 |
| Pfizer | 1 | $27 |
| Almirall LLC | 1 | $24 |
| Verrica Pharmaceuticals Inc. | 1 | $14 |
| Amgen | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,828 in reported general payments places this provider in the 95th percentile of 252 adult health providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 13 | $50,925 |
| Clobetasol Propionate | 12 | $475 |
| Triamcinolone Acetonide | 16 | $136 |
Paid to pharmacies, not to this prescriber.
Other adult health in Bellevue
- Christine FreyBellevue$4K
- Christina RedmondBellevue$2K
- Michele YinglingBellevue$1K
- George BaxterSeattle$868K
- April WatkinsSeattle$101K
- Ming Chi HsiaoTacoma$46K
- Leslie SwansonSeattle$18K
- Kindra Clark-SnustadSeattle$10K
- Alexxia RichmondSnohomish$7K
- Jonathan TurowskiMill Creek$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.